BioSpace News Archive

Compugen to Present at the JMP Securities Life Sciences Conference - May 09, 2023

Compugen Ltd., a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced that management will present at the JMP Securities Life Sciences Conference, on Tuesday, May 16, 2023 at 9:00 AM ET.

May 9, 2023
·
1 min read
Bio NC

RedHill Publishes New Talicia® Data on Generic Non-Bioequivalence in AP&T and Presents New Dosing Data at Digestive Disease Week

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced two distinct sets of new Talicia[3] data focused on generic non-bioequivalence and on dosing regimens.

May 9, 2023
·
14 min read
Evogene Ag-Seed Division Awarded Prestigious €1.2M Horizon Grant to Develop Oil-Seed Crops with High CO2 Assimilation and Drought Tolerance

The Ag-Seed Division of Evogene Ltd. has announced that it has been granted a prestigious EU Horizon grant of €1.2 million, to support the creation of oil-seed crops that have high carbon-dioxide assimilation and enhanced drought tolerance.

May 9, 2023
·
8 min read
Alkermes Announces Two Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Alkermes plc announced the acceptance of two abstracts related to nemvaleukin alfa, the company’s novel, investigational, engineered interleukin-2 variant immunotherapy, for presentation at the American Society of Clinical Oncology Annual Meeting, taking place in Chicago June 2-6, 2023.

May 9, 2023
·
6 min read
Genetown

Ascidian Therapeutics to Present New Data From Its Lead Program Targeting ABCA4 Retinopathies at the ASGCT 2023 Annual Meeting

Ascidian Therapeutics announced that Head of Research Robert Bell, Ph.D., will present new data from its lead ABCA4 program at the Twenty-Sixth Annual Meeting of the American Society of Gene and Cell Therapy.

May 9, 2023
·
3 min read
Genetown

Kernal Biologics to Present at Locust Walk RNA Innovation Conference

Kernal Bio announced that Yusuf Erkul, M.D., Co-founder & CEO, will present the company’s novel mRNA 2.0 platform at the Locust Walk RNA Innovation Conference on Tuesday, May 9, 2023, at 1:00 p.m. ET.

May 9, 2023
·
2 min read
Genetown

Flare Therapeutics Named to Inc. Magazine’s Annual List of Best Workplaces for 2023

Flare Therapeutics Inc., a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases, has been named to Inc. magazine’s annual Best Workplaces list.

May 9, 2023
·
3 min read
Business

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2023

ESSA Pharma Inc., a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, provided a corporate update and reported financial results for the fiscal second quarter ended March 31, 2023.

May 9, 2023
·
10 min read
Biotech Beach

Ionis to present at upcoming investor conferences - May 09, 2023

Ionis Pharmaceuticals, Inc. announced that management will participate in fireside chats at the following investor conferences.

May 9, 2023
·
1 min read
Genetown

Syros to Present at JMP Securities 2023 Life Sciences Conference

Syros Pharmaceuticals announced that its Chief Executive Officer, Nancy Simonian, M.D., will participate in a fireside chat at the JMP Securities 2023 Life Sciences Conference.

May 9, 2023
·
1 min read